Health Catalyst to Acquire Upfront Healthcare

Deal News | Jan 16, 2025 | Baird Capital

Health Catalyst to Acquire Upfront Healthcare

Health Catalyst, a prominent provider of data and analytics technology to healthcare organizations, has announced the signing of a definitive agreement to acquire Upfront Healthcare Services. Upfront is recognized for its next-generation patient engagement platform. The acquisition is anticipated to close in the first quarter of 2025. Baird Capital, which initially invested in Upfront Healthcare in 2020, played a key role in guiding the company through previous strategic expansions, including a notable growth-focused Series C round in 2022 and the acquisition of PatientBond. Baird Capital’s backing has proven instrumental in Upfront’s evolution, and this acquisition marks a significant step in combining their expertise with Health Catalyst's extensive health data analytics services, thereby enhancing patient engagement solutions in the healthcare sector.

Sectors

  • Healthcare Technology
  • Private Equity

Geography

  • United States – Both Health Catalyst and Upfront Healthcare are companies based in the United States, and the transaction is occurring within this geographical market.

Industry

  • Healthcare Technology – The industry involves the use of technology and analytics to improve healthcare services, which is the core business of both Health Catalyst and Upfront Healthcare.
  • Private Equity – Baird Capital is a private equity firm that has invested in Upfront Healthcare and supported its growth through strategic investments, relevant to the transaction.

Financials

  • Not Specified – Financial terms of the acquisition have not been disclosed in the article.

Participants

NameRoleTypeDescription
Health Catalyst, Inc.AcquirerCompanyA leading provider of data and analytics technology and services to healthcare organizations.
Upfront Healthcare Services, Inc.TargetCompanyA next-generation patient engagement platform provider.
Baird CapitalInvestorCompanyA private equity firm that invested in Upfront Healthcare and supported its growth.